Literature DB >> 9276420

Study of Norwalk virus and Mexico virus infections at Ga-Rankuwa Hospital, Ga-Rankuwa, South Africa.

T K Smit1, A D Steele, I Peenze, X Jiang, M K Estes.   

Abstract

Small round-structured viruses (SRSVs) or Norwalk-like viruses have been implicated as an important causative agent of gastroenteritis outbreaks. We used the relatively newly developed recombinant enzyme immunoassays (EIAs) to determine the seroprevalence of Norwalk virus (NV) and Mexico virus (MxV) in a family-based cohort and an antenatal clinic cohort at Ga-Rankuwa Hospital, Ga-Rankuwa, South Africa. High prevalences (96 to 99%) of anti-NV and anti-MxV antibodies were detected in both cohorts. We also investigated the pattern of antibody acquisition in a cohort of infants and young children without gastroenteritis and found that by 48 months of age all children had acquired adult antibody levels to both these viruses. Lastly, we tested 276 stool specimens collected from infants and young children with gastroenteritis for the presence of NV or MxV antigen by recombinant EIAs to each virus, by electron microscopy (EM), and by reverse transcription (RT)-PCR. NV and MxV antigens were present in 1.8 and 4.3% of the stool specimens, respectively, by the recombinant EIAs; 9.2% were positive for SRSVs by EM, and 25% of these SRSVs gave a positive result by RT-PCR for primer pair 35-36 directed to a region of the RNA-dependent RNA polymerase gene. The seroprevalence studies indicate a high level of exposure to these viruses in both children and adults. Although the viral antigens are not highly prevalent in diarrheal stools, it was determined by the two assays for NV and MxV that children are, nevertheless, infected early in life.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276420      PMCID: PMC229972          DOI: 10.1128/jcm.35.9.2381-2385.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein.

Authors:  X Jiang; M Wang; D Y Graham; M K Estes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Detection of Norwalk virus in stool by polymerase chain reaction.

Authors:  X Jiang; J Wang; D Y Graham; M K Estes
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

3.  Enteropathogens isolated from children with gastro-enteritis at Ga-Rankuwa Hospital, South Africa.

Authors:  A D Steele; A Geyer; J J Alexander; H H Crewe-Brown; P J Fripp
Journal:  Ann Trop Paediatr       Date:  1988-12

4.  The isolation and characterization of a Norwalk virus-specific cDNA.

Authors:  S M Matsui; J P Kim; H B Greenberg; W Su; Q Sun; P C Johnson; H L DuPont; L S Oshiro; G R Reyes
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Characterization of the Snow Mountain agent of viral gastroenteritis.

Authors:  H P Madore; J J Treanor; R Dolin
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

6.  Norwalk virus genome cloning and characterization.

Authors:  J N Xi; D Y Graham; K N Wang; M K Estes
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

7.  Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay.

Authors:  N R Blacklow; G Cukor; M K Bedigian; P Echeverria; H B Greenberg; D S Schreiber; J S Trier
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

8.  Prevalence of antibodies to human caliciviruses (HuCVs) in Kuwait established by ELISA using baculovirus-expressed capsid antigens representing two genogroups of HuCVs.

Authors:  D H Dimitrov; S A Dashti; J M Ball; E Bishbishi; K Alsaeid; X Jiang; M K Estes
Journal:  J Med Virol       Date:  1997-02       Impact factor: 2.327

9.  Proteins of Norwalk virus.

Authors:  H B Greenberg; J R Valdesuso; A R Kalica; R G Wyatt; V J McAuliffe; A Z Kapikian; R M Chanock
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

10.  Acquisition of serum antibody to Norwalk Virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh.

Authors:  R E Black; H B Greenberg; A Z Kapikian; K H Brown; S Becker
Journal:  J Infect Dis       Date:  1982-04       Impact factor: 5.226

View more
  10 in total

Review 1.  Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses.

Authors:  R L Atmar; M K Estes
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

2.  Detection of Norwalk virus and other genogroup 1 human caliciviruses by a monoclonal antibody, recombinant-antigen-based immunoglobulin M capture enzyme immunoassay.

Authors:  J P Brinker; N R Blacklow; M K Estes; C L Moe; K J Schwab; J E Herrmann
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

3.  Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Authors:  Jackie E Mahar; Nicole C Donker; Karin Bok; Gert H Talbo; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

4.  The importance of intergenic recombination in norovirus GII.3 evolution.

Authors:  Jackie E Mahar; Karin Bok; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

5.  Exposure to human and bovine noroviruses in a birth cohort in southern India from 2002 to 2006.

Authors:  Vipin Kumar Menon; Santosh George; Aruna A Shanti; Anuradha Saravanabavan; Prasanna Samuel; Sasirekha Ramani; Mary K Estes; Gagandeep Kang
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

6.  Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses.

Authors:  Vesselin T Tomov; Lisa C Osborne; Douglas V Dolfi; Gregory F Sonnenberg; Laurel A Monticelli; Kathleen Mansfield; Herbert W Virgin; David Artis; E John Wherry
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

7.  Genetic susceptibility to norovirus GII.3 and GII.4 infections in Chinese pediatric diarrheal disease.

Authors:  Pengbo Liu; Xiaoqin Wang; Joong-Chul Lee; Peter Teunis; Senke Hu; Helen Tang Paradise; Christine Moe
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

8.  Comparison of age-stratified seroprevalence of antibodies against norovirus GII in India and the United Kingdom.

Authors:  Vipin Kumar Menon; Santosh George; Farah Aladin; Sameena Nawaz; Rajiv Sarkar; Ben Lopman; James J Gray; Miren Iturriza Gomara; Gagandeep Kang
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

9.  Norovirus Seroprevalence among Adults in the United States: Analysis of NHANES Serum Specimens from 1999-2000 and 2003-2004.

Authors:  Amy E Kirby; Yvonne Kienast; Wanzhe Zhu; Jerusha Barton; Emeli Anderson; Melissa Sizemore; Jan Vinje; Christine L Moe
Journal:  Viruses       Date:  2020-02-05       Impact factor: 5.048

10.  Profiling of humoral immune responses to norovirus in children across Europe.

Authors:  Nele Villabruna; Ray W Izquierdo-Lara; Claudia M E Schapendonk; Erwin de Bruin; Felicity Chandler; Tran Thi Nhu Thao; Brenda M Westerhuis; Janko van Beek; Louise Sigfrid; Carlo Giaquinto; Herman Goossens; Julia A Bielicki; Malte Kohns Vasconcelos; Pieter L A Fraaij; Marion P G Koopmans; Miranda de Graaf
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.